NASDAQ
PIII
Last Price
US $10.43
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
P3 Health Partners Inc. cash flow to debt ratio of -32.03% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
P3 Health Partners Inc.'s free cash flow has increased -17.22% from $-110.13M last year to $-91.16M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
P3 Health Partners Inc.'s debt to equity ratio is -0.43, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Healthy debt to equity ratio development.
P3 Health Partners Inc.'s debt to equity ratio is -0.43, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Net debt/EBITDA.
P3 Health Partners Inc. has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
P3 Health Partners Inc.'s interest coverage ratio is -3.55, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
P3 Health Partners Inc.'s profit margin has increased (-5.29%) in the last year from -9.05% to -8.57%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
P3 Health Partners Inc.'s short-term liabilities of $545.26M exceed its short-term assets of $133.08M, signaling financial risk
Decreasing performance - ROA.
P3 Health Partners Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Increasing performance - Absolute return on equity.
P3 Health Partners Inc.'s return on equity of 184.97%, is higher than 15.00%, indicating good performance
Decreasing performance - Earnings quality.
P3 Health Partners Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
P3 Health Partners Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
P3 Health Partners Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
P3 Health Partners Inc. has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
P3 Health Partners Inc.'s yearly earnings has decreased 8.91% since last year from $-135.85M to $-147.95M, signaling decreasing performance
Decreasing performance - Healthy revenue growth.
P3 Health Partners Inc.'s yearly revenue has decreased -2.76% since last year from $1.50G to $1.46G, signaling decreasing performance
Decreasing performance - ROIC.
ROIC -107.99% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
P3 Health Partners Inc.'s 3-year revenue CAGR of 11.61% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
P3 Health Partners Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
P3 Health Partners Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
P3 Health Partners Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
P3 Health Partners Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
P3 Health Partners Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
P3 Health Partners Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
P3 Health Partners Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
P3 Health Partners Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails
Undervalued - P/S ratio.
P3 Health Partners Inc. has a price-to-sales ratio of 0.02x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
184.97%
Return on equity
ROIC: -107.99%
Valuation History
-0.25X
Price to Earnings
EV/EBITDA: -0.50X
Cash flow
Profit margin
-31.18%
(FY vs FY)
Cash flow Y/Y
-21.30%
(FY vs FY)
Fair Value
Market $10.43
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.